NDC 42227-083

Cinryze

Human C1-esterase Inhibitor

Cinryze is a Kit in the Plasma Derivative category. It is labeled and distributed by Viropharma Biologics Llc. The primary component is .

• Product ID: 42227-083_0fb47377-d040-43b5-8502-f788c67c06aa
• NDC: 42227-083
• Product Type: Plasma Derivative
• Proprietary Name: Cinryze
• Generic Name: Human C1-esterase Inhibitor
• Dosage Form: Kit
• Marketing Start Date: 2021-01-15
• Marketing Category: BLA / BLA
• Application Number: BLA125267
• Labeler Name: ViroPharma Biologics LLC
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 42227-083-01

1 KIT in 1 CARTON (42227-083-01) * 5 mL in 1 VIAL, SINGLE-USE (42227-081-01) * 5 mL in 1 VIAL, GLASS (64764-515-50)

• Marketing Start Date: 2021-01-15
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Cinryze" or generic name "Human C1-esterase Inhibitor"

NDC	Brand Name	Generic Name
42227-081	Cinryze	HUMAN C1-ESTERASE INHIBITOR
42227-083	Cinryze	HUMAN C1-ESTERASE INHIBITOR
63833-825	Berinert	HUMAN C1-ESTERASE INHIBITOR
63833-828	HAEGARDA	HUMAN C1-ESTERASE INHIBITOR
63833-829	HAEGARDA	HUMAN C1-ESTERASE INHIBITOR